LEXARIA BIOSCIENCE CORP. Increase (Decrease) in Prepaid Expense
LEXARIA BIOSCIENCE CORP. (LEXX) reported Increase (Decrease) in Prepaid Expense of -$337.43 thousand for the 6-month period ending 2025-02-28, per its 10-Q filed 2025-04-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2025-04-14
- LEXARIA BIOSCIENCE CORP. increase (decrease) in prepaid expense for the quarter ending 2025-02-28 was $406.26K, a 202.09% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in prepaid expense for the quarter ending 2024-11-30 was -$743.70K.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in prepaid expense for the quarter ending 2024-08-31 was $808.27K.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in prepaid expense for the quarter ending 2024-05-31 was $112.75K.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in prepaid expense for fiscal 2024 was $641.03K.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in prepaid expense for fiscal 2023 was -$29.98K.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in prepaid expense for fiscal 2022 was -$257.51K, a 287.75% decline from fiscal 2021.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in prepaid expense for fiscal 2021 was $137.16K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 6 month as first filed | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 9 month as first filed | Increase (Decrease) in Prepaid Expense 12 month | Increase (Decrease) in Prepaid Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-02-28 | $406.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-04-14 | -$337.43K 10-Q · filed 2025-04-14 | $470.84K derived: sum of 3 quarters · filed 2025-04-14 | $583.59K derived: sum of 4 quarters · filed 2025-04-14 | |||
| 2024-11-30 | -$743.70K 10-Q · filed 2025-01-10 | $64.58K derived: sum of 2 quarters · filed 2025-01-10 | $177.32K derived: sum of 3 quarters · filed 2025-01-10 | $311.81K derived: sum of 4 quarters · filed 2025-04-14 | |||
| 2024-08-31 | $808.27K derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | $921.02K derived: sum of 2 quarters · filed 2024-11-26 | $1.06M derived: sum of 3 quarters · filed 2025-04-14 | $641.03K 10-K · filed 2024-11-26 | |||
| 2024-05-31 | $112.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-12 | $247.24K derived: sum of 2 quarters · filed 2025-04-14 | -$167.24K 10-Q · filed 2024-07-12 | -$250.19K derived: sum of 4 quarters · filed 2025-04-14 | |||
| 2024-02-29 | $134.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-04-14 | -$279.99K 10-Q · filed 2025-04-14 | $279.99K 10-Q · filed 2024-04-09 | -$362.94K derived: sum of 3 quarters · filed 2025-04-14 | -$567.13K derived: sum of 4 quarters · filed 2025-04-14 | ||
| 2023-11-30 | -$414.47K 10-Q · filed 2025-01-10 | -$497.43K derived: sum of 2 quarters · filed 2025-01-10 | -$701.62K derived: sum of 3 quarters · filed 2025-01-10 | -$128.03K derived: sum of 4 quarters · filed 2025-01-10 | |||
| 2023-08-31 | -$82.96K derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | -$287.15K derived: sum of 2 quarters · filed 2024-11-26 | $286.44K derived: sum of 3 quarters · filed 2024-11-26 | -$29.98K 10-K · filed 2024-11-26 | $29.98K 10-K · filed 2023-11-20 | ||
| 2023-05-31 | -$204.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-12 | $369.40K derived: sum of 2 quarters · filed 2024-07-12 | $52.98K 10-Q · filed 2024-07-12 | -$52.98K 10-Q · filed 2023-07-14 | -$366.47K derived: sum of 4 quarters · filed 2024-07-12 | ||
| 2023-02-28 | $573.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-04-09 | $257.17K 10-Q · filed 2024-04-09 | -$257.17K 10-Q · filed 2023-04-14 | -$162.28K derived: sum of 3 quarters · filed 2024-04-09 | $96.95K derived: sum of 4 quarters · filed 2024-04-09 | ||
| 2022-11-30 | -$316.42K 10-Q · filed 2024-01-12 | -$735.87K derived: sum of 2 quarters · filed 2024-01-12 | -$476.63K derived: sum of 3 quarters · filed 2024-01-12 | -$491.90K derived: sum of 4 quarters · filed 2024-01-12 | |||
| 2022-08-31 | -$419.45K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-20 | -$160.22K derived: sum of 2 quarters · filed 2023-11-20 | -$175.48K derived: sum of 3 quarters · filed 2023-11-20 | -$257.51K 10-K · filed 2023-11-20 | $257.51K 10-K · filed 2022-11-28 | ||
| 2022-05-31 | $259.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-07-14 | $243.97K derived: sum of 2 quarters · filed 2023-07-14 | $161.94K 10-Q · filed 2023-07-14 | $310.76K derived: sum of 4 quarters · filed 2023-07-14 | |||
| 2022-02-28 | -$15.26K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-04-14 | -$97.29K 10-Q · filed 2023-04-14 | $51.52K derived: sum of 3 quarters · filed 2023-04-14 | -$141.78K derived: sum of 4 quarters · filed 2023-04-14 | |||
| 2021-11-30 | -$82.03K 10-Q/A · filed 2023-01-18 | $66.78K derived: sum of 2 quarters · filed 2023-01-18 | -$126.52K derived: sum of 3 quarters · filed 2023-01-18 | $101.21K derived: sum of 4 quarters · filed 2023-01-18 | |||
| 2021-08-31 | $148.81K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | -$44.49K derived: sum of 2 quarters · filed 2022-11-28 | $183.24K derived: sum of 3 quarters · filed 2022-11-28 | $137.16K 10-K · filed 2022-11-28 | -$137.16K 10-K · filed 2021-11-29 | ||
| 2021-05-31 | -$193.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-07-14 | $34.42K derived: sum of 2 quarters · filed 2022-07-14 | -$11.66K 10-Q · filed 2022-07-14 | $11.66K 10-Q · filed 2021-07-15 | -$104.81K derived: sum of 4 quarters · filed 2022-07-14 | ||
| 2021-02-28 | $227.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-04-11 | $181.65K 10-Q · filed 2022-04-11 | $88.50K derived: sum of 3 quarters · filed 2022-04-11 | $72.65K derived: sum of 4 quarters · filed 2022-04-11 | |||
| 2020-11-30 | -$46.08K 10-Q · filed 2021-01-14 | -$139.23K derived: sum of 2 quarters · filed 2021-11-29 | -$155.08K derived: sum of 3 quarters · filed 2021-11-29 | -$186.39K derived: sum of 4 quarters · filed 2021-11-29 | |||
| 2020-08-31 | -$93.16K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | -$109.00K derived: sum of 2 quarters · filed 2021-11-29 | -$140.31K derived: sum of 3 quarters · filed 2021-11-29 | -$113.17K 10-K · filed 2021-11-29 | $113.17K 10-K · filed 2020-10-15 | ||
| 2020-05-31 | -$15.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-15 | -$47.15K derived: sum of 2 quarters · filed 2021-07-15 | -$20.01K 10-Q · filed 2021-07-15 | $20.01K 10-Q · filed 2020-06-29 | -$73.89K derived: sum of 4 quarters · filed 2021-07-15 | ||
| 2020-02-29 | -$31.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-14 | -$4.17K 10-Q · filed 2021-04-14 | -$58.05K derived: sum of 3 quarters · filed 2021-04-14 | -$84.35K derived: sum of 4 quarters · filed 2021-04-14 | |||
| 2019-11-30 | $27.14K 10-Q · filed 2021-01-14 | -$26.74K derived: sum of 2 quarters · filed 2021-01-14 | -$53.04K derived: sum of 3 quarters · filed 2021-01-14 | -$87.36K derived: sum of 4 quarters · filed 2021-01-14 | |||
| 2019-08-31 | -$53.88K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-15 | -$80.18K derived: sum of 2 quarters · filed 2020-10-15 | -$114.50K derived: sum of 3 quarters · filed 2020-10-15 | -$124.81K 10-K · filed 2020-10-15 | |||
| 2019-05-31 | -$26.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-29 | -$60.62K derived: sum of 2 quarters · filed 2020-06-29 | -$70.92K 10-Q · filed 2020-06-29 | -$39.07K derived: sum of 4 quarters · filed 2020-06-29 | |||
| 2019-02-28 | -$34.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-03 | -$44.63K 10-Q · filed 2020-04-03 | -$12.78K derived: sum of 3 quarters · filed 2020-04-03 | -$27.74K derived: sum of 4 quarters · filed 2020-04-03 | |||
| 2018-11-30 | -$10.30K 10-Q · filed 2020-01-09 | $21.55K derived: sum of 2 quarters · filed 2020-01-09 | $6.58K derived: sum of 3 quarters · filed 2020-01-09 | $125.29K derived: sum of 4 quarters · filed 2020-01-09 | |||
| 2018-08-31 | $31.85K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-14 | $16.89K derived: sum of 2 quarters · filed 2019-11-14 | $135.59K derived: sum of 3 quarters · filed 2019-11-14 | $44.04K 10-K · filed 2019-11-14 | |||
| 2018-05-31 | -$14.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-08 | $103.74K derived: sum of 2 quarters · filed 2019-07-08 | $12.19K 10-Q · filed 2019-07-08 | ||||
| 2018-02-28 | $118.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | $27.16K 10-Q · filed 2019-04-15 | |||||
| 2017-11-30 | -$91.55K 10-Q · filed 2019-01-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |